You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mild to moderate asthma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma, Mild Asthma, Moderate Asthma Trial in Genova

Recruiting
  • Asthma
  • +2 more
    • Genova, Italy
      IRCCS Ospedale Policlinico San Martino
    Feb 7, 2022

    Asthma, Airway Obstruction, Airway Remodeling Trial (Salbutamol, Ipratropium Bromide, Salbutamol plus Ipratropium Bromide)

    Not yet recruiting
    • Asthma
    • +3 more
    • (no location specified)
    Sep 19, 2022

    Asthma Trial in London, Manchester (Human beta common receptor antagonist mAb, Placebo)

    Recruiting
    • Asthma
    • Human beta common receptor antagonist monoclonal antibody
    • Placebo
    • Berlin, Germany
    • +2 more
    Dec 21, 2022

    Step-up in Bronchial Asthma as a New End Point (SURFE)

    Not yet recruiting
    • Bronchial Asthma
      • (no location specified)
      Nov 19, 2022

      Asthma, Allergic Trial (Biocide)

      Not yet recruiting
      • Asthma, Allergic
      • Biocide
      • (no location specified)
      Apr 22, 2022

      Asthma Trial in Poland (Ectoin® Inhalation Solution)

      Enrolling by invitation
      • Asthma
      • Ectoin® Inhalation Solution
      • Białystok, Poland
      • +4 more
      Jan 24, 2023

      Atopic Dermatitis, Psoriasis, Asthma Trial in United Kingdom (EDP1867, Placebo)

      Completed
      • Atopic Dermatitis
      • +2 more
      • Manchester, Greater Manchester, United Kingdom
      • +6 more
      Oct 6, 2022

      Airway Remodeling and Rhinovirus in Asthmatics

      Recruiting
      • Asthma
      • Respiratory Disease
      • HRV-39
      • Calgary, Alberta, Canada
        University of Calgary
      Mar 7, 2023

      Asthma Trial in Berlin, Belfast (SAR443765, Placebo, Salbutamol or levosalbutamol)

      Active, not recruiting
      • Asthma
      • Berlin, Germany
      • +1 more
      Jan 6, 2023

      Asthma Trial in Manchester (KN-002)

      Recruiting
      • Asthma COPD
      • Manchester, United Kingdom
        Medicines Evaluation Unit
      Aug 30, 2022

      Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic Trial in Spain (10,000 MM09, 30,000 MM09, Placebo subcutaneous)

      Recruiting
      • Rhinitis, Allergic
      • +2 more
      • 10,000 MM09
      • +2 more
      • Elche, Alicante, Spain
      • +16 more
      Mar 23, 2022

      Asthma Trial (Asmanex twisthaler, Placebo for Asmanex twisthaler)

      Terminated
      Has Results
      • Asthma
      • Asmanex twisthaler
      • Placebo for Asmanex twisthaler
      • (no location specified)
      Feb 7, 2022

      Asthma Trial (mometasone furoate dry powder inhaler, Budesonide DPI)

      Completed
      Has Results
      • Asthma
      • mometasone furoate dry powder inhaler
      • Budesonide DPI
      • (no location specified)
      Feb 7, 2022

      Mild or Moderate Asthma With Allergic Sensitization Trial in Indianapolis (5-Hydroxytryptophan, Placebo)

      Recruiting
      • Mild or Moderate Asthma With Allergic Sensitization
      • Indianapolis, Indiana
        Indiana University
      Jan 20, 2022

      House Dust Mite Allergy, Perennial Allergic Rhinitis, Allergic Rhinoconjunctivitis Trial in Spain (MM09 allergoid-mannan

      Not yet recruiting
      • House Dust Mite Allergy
      • +3 more
      • MM09 allergoid-mannan conjugates subcutaneous (3.000 UTm/mL)
      • +4 more
      • Elche, Alicante, Spain
      • +15 more
      Nov 17, 2022

      Asthma Trial in Hungary, South Africa, United Kingdom (Tezepelumab)

      Recruiting
      • Asthma
      • Tezepelumab
      • Budapest, Hungary
      • +6 more
      Mar 18, 2022

      Asthma Trial in Manchester, Belfast (TD-8236, Placebo)

      Completed
      • Asthma
      • Manchester, England, United Kingdom
      • +1 more
      Sep 28, 2021

      Asthma Trial (Mometasone Furoate)

      Terminated
      Has Results
      • Asthma
      • Mometasone Furoate
      • (no location specified)
      Feb 7, 2022

      Asthma Trial in Enschede, Nijverdal, Rotterdam (ELLIPTA, BREEZHALER)

      Completed
      • Asthma
      • ELLIPTA
      • BREEZHALER
      • Enschede, Netherlands
      • +2 more
      Oct 7, 2021

      Asthma Trial in China (Budesonide 200 microgram/Puff, HFA MDI, Budesonide 100 microgram/Actuation Powder for Inhalation)

      Completed
      • Asthma
      • Budesonide 200 microgram/Puff, HFA MDI
      • Budesonide 100 microgram/Actuation Powder for Inhalation
      • Beijing, Beijing, China
      • +12 more
      Nov 28, 2021

      Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic Trial in Spain (10,000 MG01 +10,000 T521, 30,000 MG01 +10,000 T521,

      Recruiting
      • Rhinitis, Allergic
      • +2 more
      • 10,000 MG01 +10,000 T521
      • +2 more
      • Tarancon, Cuenca, Spain
      • +13 more
      Aug 13, 2021

      Asthma Trial in Germany, United Kingdom (GSK3511294, Placebo, Salbutamol/albuterol)

      Completed
      Has Results
      • Asthma
      • Hannover, Niedersachsen, Germany
      • +4 more
      Feb 5, 2021

      Asthma Trial in Ottawa, Montreal (Indacaterol maleate, Placebo)

      Completed
      • Asthma
      • Indacaterol maleate
      • Placebo
      • Ottawa, Ontario, Canada
      • +1 more
      Dec 16, 2020

      Bronchial Asthma Trial in Medford (Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation), Ventolin HFA 90Mcg/Actuation

      Not yet recruiting
      • Bronchial Asthma
      • Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)
      • +3 more
      • Medford, Oregon
        Velocity CLinical Research
      Nov 23, 2023

      Hallux Valgus Deformity Trial (Conservative treatment with orthopedic aid/wide shoe for participants with mild to moderate

      Not yet recruiting
      • Hallux Valgus Deformity
      • Conservative treatment with orthopedic aid/wide shoe for participants with mild to moderate hallux valgus
      • Operation for mild to moderate hallux valgus
      • (no location specified)
      Oct 27, 2023